Opaleye Management Inc. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$498.9B
Holdings
41
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (41 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HROWHARROW HEALTH INC | 3,905,000 | $119.3B | 23.90% | |
| 2 | ETONETON PHARMACEUTICALS INC | 2,860,000 | $40.8B | 8.17% | |
| 3 | IMNMIMMUNOME INC | 3,529,581 | $32.8B | 6.58% | |
| 4 | SNWVSANUWAVE HEALTH INC | 980,000 | $32.2B | 6.45% | |
| 5 | LQDALIQUIDIA CORPORATION | 2,475,000 | $30.8B | 6.18% | |
| 6 | CDXSCODEXIS INC | 12,600,000 | $30.7B | 6.16% | |
| 7 | RYTMRHYTHM PHARMACEUTICALS INC | 475,000 | $30.0B | 6.02% | |
| 8 | TGTXTG THERAPEUTICS INC | 535,000 | $19.3B | 3.86% | |
| 9 | OCULOCULAR THERAPEUTIX INC | 1,595,000 | $14.8B | 2.97% | |
| 10 | ARVNARVINAS INC | 1,680,000 | $12.4B | 2.48% | |
| 11 | LRMRLARIMAR THERAPEUTICS INC | 4,110,000 | $11.9B | 2.38% | |
| 12 | IRONDISC MEDICINE INC | 186,418 | $9.9B | 1.98% | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 500,000 | $8.6B | 1.71% | |
| 14 | VIGLVIGIL NEUROSCIENCES INC | 1,000,000 | $8.0B | 1.59% | |
| 15 | TARAPROTARA THERAPEUTICS INC | 855,000 | $7.4B | 1.48% | |
| 16 | CGONCG ONCOLOGY INC | 266,000 | $6.9B | 1.39% | |
| 17 | XOMAXOMA CORP DEL | 255,087 | $6.4B | 1.29% | |
| 18 | EWTXEDGEWISE THERAPEUTICS INC | 490,000 | $6.4B | 1.29% | |
| 19 | STOKSTOKE THERAPEUTICS INC | 562,120 | $6.4B | 1.28% | |
| 20 | ANIKANIKA THERAPEUTICS INC | 588,797 | $6.2B | 1.25% | |
| 21 | GOSS 5 06/01/27GOSSAMER BIO INC | 11,500,000 | $5.9B | 1.19% | |
| 22 | PTGXPROTAGONIST THERAPEUTICS INC | 105,000 | $5.8B | 1.16% | |
| 23 | DNAGINKGO BIOWORKS HOLDINGS | 500,000 | $5.6B | 1.13% | |
| 24 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 6,000,000 | $4.6B | 0.91% | |
| 25 | GOSSGOSSAMER BIO INC | 3,545,000 | $4.4B | 0.87% | |
| 26 | RZLTREZOLUTE INC | 903,442 | $4.0B | 0.81% | |
| 27 | RVMDREVOLUTION MEDICINES INC | 105,000 | $3.9B | 0.77% | |
| 28 | EPIEURESSA PHARMA INC | 2,209,998 | $3.8B | 0.75% | |
| 29 | CRGXCARGO THERAPEUTICS INC | 666,503 | $2.7B | 0.55% | |
| 30 | MBXMBX BIOSCIENCES INC | 239,319 | $2.7B | 0.55% | |
| 31 | ZYMEZYMEWORKS INC | 210,000 | $2.6B | 0.53% | |
| 32 | ALMSALUMIS INC | 775,000 | $2.3B | 0.47% | |
| 33 | ZNTLZENTALIS PHARMACEUTICALS INC | 1,924,300 | $2.2B | 0.45% | |
| 34 | TRVITREVI THERAPEUTICS INC | 390,000 | $2.1B | 0.43% | |
| 35 | RCELAVITA MEDICAL INC | 389,519 | $2.1B | 0.41% | |
| 36 | IRDOPUS GENETICS INC | 1,220,000 | $1.1B | 0.23% | |
| 37 | DERMJOURNEY MEDICAL CORP | 95,000 | $682.1M | 0.14% | |
| 38 | —ELEVATION ONCOLOGY INC | 1,442,061 | $529.4M | 0.11% | |
| 39 | IBIOIBIO INC | 375,000 | $285.0M | 0.06% | |
| 40 | PEPGPEPGEN INC | 240,000 | $266.4M | 0.05% | |
| 41 | ADGMADAGIO MED HLDGS INC | 110,571 | $143.7M | 0.03% |